arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2402.04209cs.LGcs.AI
收藏

非重症监护患者急性肾损伤预测:一项回顾性外部与内部验证研究

Acute kidney injury prediction for non-critical care patients: a retrospective external and internal validation study

University of Florida(佛罗里达大学);University of Pittsburgh(匹兹堡大学)
Esra Adiyeke, Yuanfang Ren, Benjamin Shickel, Matthew M. Ruppert, Ziyuan Guan, Sandra L. Kane-Gill, Raghavan Murugan, Nabihah Amatullah, Britney A. Stottlemyer,… 展开作者

Esra Adiyeke, Yuanfang Ren, Benjamin Shickel, Matthew M. Ruppert, Ziyuan Guan, Sandra L. Kane-Gill, Raghavan Murugan, Nabihah Amatullah, Britney A. Stottlemyer, Tiffany L. Tran, Dan Ricketts, Christopher M Horvat, Parisa Rashidi, Azra Bihorac, Tezcan Ozrazgat-Baslanti

AI总结:

本研究利用两个医疗中心的大规模非重症患者数据,开发并验证了深度学习和传统机器学习模型,用于预测48小时内进展至2期及以上急性肾损伤,发现本地模型在外部验证时判别能力略有下降,但关键影响特征保持一致。

摘要:

背景:急性肾损伤(AKI)是肾脏排泄功能下降,发生在高达18%的住院患者中。AKI的进展可能导致不可逆的肾脏损害。方法:这项回顾性队列研究纳入了在匹兹堡大学医学中心(UPMC)非重症监护病房(n = 46,815)和佛罗里达大学健康中心(UFH)(n = 127,202)住院的成年患者。我们开发并比较了深度学习和传统机器学习模型,以预测未来48小时内进展至2期或更高阶段AKI的情况。我们为每个站点训练了本地模型(UFH模型在UFH上训练,UPMC模型在UPMC上训练),并使用来自两个站点的患者开发队列训练了一个独立模型(UFH-UPMC模型)。我们在每个站点对模型进行了内部和外部验证,并按性别和种族进行了亚组分析。结果:UFH和UPMC患者中分别有3%(n=3,257)和8%(n=2,296)发生2期或更高阶段AKI。UFH测试队列的受试者工作特征曲线下面积(AUROC)值介于0.77(UPMC模型)和0.81(UFH模型)之间,而UPMC测试队列的AUROC值介于0.79(UFH模型)和0.83(UPMC模型)之间。UFH-UPMC模型在UFH测试队列中实现了0.81(95%置信区间[CI] [0.80, 0.83])的AUROC,在UPMC测试队列中实现了0.82(95% CI [0.81, 0.84])的AUROC;精确率-召回率曲线下面积(AUPRC)在UFH测试队列中为0.6(95% CI [0.05, 0.06]),在UPMC测试队列中为0.13(95% CI [0.11, 0.15])。动力学估算的肾小球滤过率、肾毒性药物负担和血尿素氮在各模型和医疗中心中仍然是影响最大的前三个特征。结论:本地开发的模型在另一机构测试时显示出略微降低的判别能力,而影响最大的特征集在各模型和站点中保持一致。

英文摘要:

Background: Acute kidney injury (AKI), the decline of kidney excretory function, occurs in up to 18% of hospitalized admissions. Progression of AKI may lead to irreversible kidney damage. Methods: This retrospective cohort study includes adult patients admitted to a non-intensive care unit at the University of Pittsburgh Medical Center (UPMC) (n = 46,815) and University of Florida Health (UFH) (n = 127,202). We developed and compared deep learning and conventional machine learning models to predict progression to Stage 2 or higher AKI within the next 48 hours. We trained local models for each site (UFH Model trained on UFH, UPMC Model trained on UPMC) and a separate model with a development cohort of patients from both sites (UFH-UPMC Model). We internally and externally validated the models on each site and performed subgroup analyses across sex and race. Results: Stage 2 or higher AKI occurred in 3% (n=3,257) and 8% (n=2,296) of UFH and UPMC patients, respectively. Area under the receiver operating curve values (AUROC) for the UFH test cohort ranged between 0.77 (UPMC Model) and 0.81 (UFH Model), while AUROC values ranged between 0.79 (UFH Model) and 0.83 (UPMC Model) for the UPMC test cohort. UFH-UPMC Model achieved an AUROC of 0.81 (95% confidence interval [CI] [0.80, 0.83]) for UFH and 0.82 (95% CI [0.81,0.84]) for UPMC test cohorts; an area under the precision recall curve values (AUPRC) of 0.6 (95% CI, [0.05, 0.06]) for UFH and 0.13 (95% CI, [0.11,0.15]) for UPMC test cohorts. Kinetic estimated glomerular filtration rate, nephrotoxic drug burden and blood urea nitrogen remained the top three features with the highest influence across the models and health centers. Conclusion: Locally developed models displayed marginally reduced discrimination when tested on another institution, while the top set of influencing features remained the same across the models and sites.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑